Open Beta
TREN
MetriLume
TREN

US marketsUPC

SEC-sourced researchBeta

UPC

Universe Pharmaceuticals INC

Company comparison ↗

Data passport

CIK
0001809616
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 6, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: September 2023: 32,308,735,000.0000 USD; September 2024: 23,024,458,000.0000 USD; September 2025: 17,858,732,000.0000 USD32.3B USD0 USD0September 2023September 2024September 2025
UPC · Exact amounts and source periods · USD
Period endRevenueFiling date
September 202332,308,735,000.0000Jan 29, 2026
September 202423,024,458,000.0000Jan 29, 2026
September 202517,858,732,000.0000Jan 29, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
September 202517,858,732,000.0000-3,672,055,000.0000-5,052,319,000.000069,303,440,000.000013,173,930,000.0000Jan 29, 2026
September 202423,024,458,000.0000-8,727,298,000.0000-9,506,683,000.000067,953,393,000.000022,450,452,000.0000Jan 29, 2026
September 202332,308,735,000.0000-6,581,024,000.00001,116,775,000.0000——Jan 29, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$17.86BSeptember 2025Jan 29, 202620-F
Previous period revenueRevenues$23.02BSeptember 2024Jan 29, 202620-F
Net incomeNetIncomeLoss-$3.67BSeptember 2025Jan 29, 202620-F
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$5.05BSeptember 2025Jan 29, 202620-F
Total assetsAssets$69.3BSeptember 2025Jan 29, 202620-F
Total liabilitiesLiabilities$13.17BSeptember 2025Jan 29, 202620-F

New filings

Explore methodology ↗